Burning Rock Biotech Ltd
Diagnostics & Research
Healthcare
BNR
10.32 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
3.55
52 week high
7.90
high
3.55
52 week low
2.71
low
3.23
growth
-57.63 %
previous Close
3.56
P/E ratio
market cap
66.68 M
div yield
0
usd
Sep 2024
qoq
revenue
129 M
-5.08 %
net incoming
-35.75 M
66.91 %
eps
0.00 %
66.77 %
eps surprise
0.00 %
net profit margin
-27.79 %
51.00 %
operating incoming
-38.59 M
65.30 %
net change in cash
-34.80 M
12.18 %
cash on hand
498 M
-6.49 %
cost of revenue
36.80 M
-8.22 %
top top